Nausea still the poor relation in antiemetic therapy? the impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster

Supportive Care in Cancer

Volumn 21, Issue 3, 2013, Pages 735-748

  Pirri, Carlo ^a   Bayliss, Evan ^b   Trotter, James ^c   Olver, Ian N ^d,e   Katris, Paul ^f   Drummond, Peter ^a   Bennett, Robert ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Cancer Council Australia   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f Western Australian Clinical Oncology Group   (Australia)

Author keywords

Anorexia; Cancer; Chemotherapy; Nausea; Non pharmacological; Psychological; Quality of life; Radiotherapy; Surgery; Symptom cluster; Vomiting

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOPAMINE RECEPTOR BLOCKING AGENT; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; SEROTONIN 3 ANTAGONIST;

ADJUSTMENT; ADULT; ANOREXIA; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COMORBIDITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; FACTORIAL ANALYSIS; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH STATUS; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; NEUROSIS; OBSERVATIONAL STUDY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; SOCIAL INTERACTION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTIEMETICS; ANTINEOPLASTIC AGENTS; APPETITE; EVIDENCE-BASED MEDICINE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIME FACTORS; VOMITING; YOUNG ADULT;

EID: 84874107732     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1574-9     Document Type: Article

References (59)

1. Ballatori E, Roila F, Ruggeri B, Betti M, Sarti S, Soru G, Cruciani G, Di Maio M, Andrea B, Deuson RR (2007) The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer 15:179-185
2. The Italian Group for Antiemetic Research in Radiotherapy (IGARR) (1999) Radiation-induced emesis: a prospective observational multicenter Italian trial. Int Radiat Oncol Biol Phys 44:619-625
3. Booth CM, Clemons M, Dranitsaris G, Joy A, Young S, Callaghan W, Trudeau M, Petrella T (2007) Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol 5:374-380
4. Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 15(1):116-123
5. Molassiotis A, Yam BMC, Yung H, Chan FYC, Mok TSK (2002) Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 10:139-145
6. Djärv T, Lagergren J, Blazeby JM, Lagergren P (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 95(9):1121-1126
7. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232-v243
8. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24(27):4472-4478
9. Ballatori E, Roila F, Ruggeri B, Porrozzi S, Iannopollo M, Soru G, Cruciani G, Daniele B, Locatelli MC, Pellissier J, Deuson R (2007) The cost of chemotherapy-induced nausea and vomiting in Italy. Support Care Cancer 15(1):31-38
10. Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting - incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497-503
11. Tina Shih Y, Xu Y, Elting LS (2007) Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy. Cancer 110(3):678-685
12. Ballatori E, Roila F (2003) Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes 1:46
13. Haiderali A, Menditto L, Good M, Teitelbaum A, Wegner J (2011) Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population. Support Care Cancer 19(6):843-851
14. Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D (2003) Measuring chemotherapy-induced nausea and emesis. Cancer 98(3):645-655
15. Saxby C, Ackroyd R, Callin S, Mayland C, Kite S (2007) How should we measure emesis in palliative care? Palliat Med 21(5):369-383
16. Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189-4198
17. Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, McNulty R, Nabati L, Todaro B, Urba S, Yowell S, National comprehensive Cancer Network (NCCN) (2007) Antiemesis. J Natl Compr Canc Netw 5(1):12-33
18. Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16:201-208
19. Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, De Pouvourville G, Rubenstein EB, Daugaard G (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: perception versus reality. Cancer 100:2261-2268
20. Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270-282
21. Molassiotis A, Wengström Y, Kearney N (2010) Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Symptom Manag 39(5):847-858
22. Wilson J, Plourde JY, Marshall D, Yoshida S, Chow W, Harsanyi Z, Pearen S, Darke A (2002) Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. J Palliat Care 18(2):84-91
23. Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P (2011) Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer 19(10):1549-1563
24. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
25. Ringdal GL, Ringdal K (1993) Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses. Qual Life Res 2:129-140
26. Selby PJ, Chapman JAW, Etazadi-Amoli J, Boyd NF (1984) The development of a method for assessing quality of life of cancer patients. Br J Cancer 50:13-22
27. Beck AT, Beck RW (1972) Screening depressed patients in family practice: a rapid technic. Postgrad Med 52:81-85
28. Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41:209-218
29. Eysenck HJ, Eysenck SBG (1991) Manual of the Eysenck Personality Questionnaire (revised). Hodder & Stoughton, London
30. Tabachnick BG, Fidell LS (2007) Using multivariate statistics (fifth edition). Allyn & Bacon, Boston
31. Kirkova J, Walsh D (2007) Cancer symptom clusters - a dynamic construct. Support Care Cancer 15(9):1011-1013
32. Field A (2009) Discovering statistics using SPSS (third edition). Sage, London
33. Threlfall TJ, Thompson JR (2000) Cancer incidence and mortality in western Australia, 1998: a report of the western Australian cancer registry. Health Department of Western Australia, Perth
34. Cheng KK, Lee DT (2011) Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol 78(2):127-137
35. Gift AG, Jablonski A, Stommel M, Given CW (2004) Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 31(2):203-210
36. Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 5(4):307-313
37. Chen ML, Lin CC (2007) Cancer symptom clusters: a validation study. J Pain Symptom Manag 34:590-599
38. Wang SY, Tsai CM, Chen BC, Lin CH, Lin CC (2008) Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients. J Pain Symptom Manag 35:258-266
39. Molassiotis A, Farrell C, Bourne K, Brearley SG, Pilling M (2012) An exploratory study to clarify the cluster of symptoms predictive of nausea using random forest modelling. J Pain Symptom Manag. doi: 10.1016/j.jpainsymman.2011. 11.003
40. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y (2003) Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manag 26:1093-1104
41. Evangelista AL, Santos EM (2012) Cluster of symptoms in women with breast cancer treated with curative intent. Support Care Cancer 20(7):1499-1550
42. Kim HJ, Barsevick AM, Tulman L, McDermott PA (2008) Treatment-related symptom clusters in breast cancer: a secondary analysis. J Pain Symptom Manag 36:468-479
43. Miaskowski C, Aouizerat BE, Dodd M, Cooper B (2007) Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. J Natl Cancer Inst Monogr 37:39-46
44. Aktas A, Walsh D, Rybicki L (2010) Symptom clusters: myth or reality? Palliat Med 24(4):373-385
45. Foubert J, Vaessen G (2005) Nausea: the neglected symptom? Eur J Oncol Nurs 9:21-32
46. Bergkvist K, Wengström Y (2006) Symptom experiences during chemotherapy treatment-with focus on nausea and vomiting. Eur J Oncol Nurs 10(1):21-29
47. Molassiotis A, Stricker CT, Eaby B, Velders L, Coventry PA (2008) Understanding the concept of chemotherapy-related nausea: the patient experience. Eur J Cancer Care 17:444-453
48. Nitenberg G, Raynard B (2000) Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34(3):137-168
49. Navari RM, Gray SE, Kerr AC (2011) Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol 9(5):188-195
50. Licup N (2010) Olanzapine for nausea and vomiting. Am J Hosp Palliat Care 27(6):432-434
51. Perwitasari DA, Gelderblom H, Atthobari J, Mustofa M, Dwiprahasto I, Nortier JW, Guchelaar HJ (2011) Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics. Int J Clin Pharm 33(1):33-43
52. Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S (2008) Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 26(34):5618-5629
53. Dileo C (2006) Effects of music and music therapy on medical patients: a meta-analysis of the research and implications for the future. J Soc Integr Oncol 4(2):67-70
54. Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I (2007) Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl) 16(5):402-412
55. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting (review). Cochrane Database Syst Rev 2:CD002285
56. Adams LA, Shepard N, Caruso RA, Norling MJ, Belansky H, Cunningham RS (2009) Putting evidence into practice: evidence-based interventions to prevent and manage anorexia. Clin J Oncol Nurs 13(1):95-102
57. Berenstein EG, Ortiz Z (2005) Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2:CD004310
58. Navari RM, Brenner MC (2010) Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer 18(8):951-956
59. Molassiotis A, Borjeson S (2006) Nausea and vomiting. In: Kearney N, Richardson A (eds) Nursing patients with cancer: Principles and practice. Elsevier, Oxford, pp 415-438